Updated Jul 16, 2026
Samsara BioCapital GP, LLC is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $1.26M. Historical track record: 1/5 stars across 4 tracked purchases.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
|---|---|
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 0% |
| 90-day win rate | 0% |
| Avg 5-day return | -855.97% |
| Avg 30-day return | -1030.89% |
| Avg 90-day return | -3822.11% |
| Best 30-day return | -1030.89% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-12-06 | VTVT | vTv Therapeutics Inc. | J — Other acquisition / disposition | 58.8K | — | |
| 2024-11-27 | NGNE | Neurogene Inc. | P — Open-market purchase | 2.0K | $27.50 | $55K |
| 2024-11-27 | NGNE | Neurogene Inc. | P — Open-market purchase | 15.2K | $26.73 | $407K |
| 2024-11-27 | NGNE | Neurogene Inc. | P — Open-market purchase | 10.8K | $26.01 | $281K |
| 2024-11-27 | NGNE | Neurogene Inc. | P — Open-market purchase | 20.7K | $24.91 | $517K |
Samsara BioCapital GP, LLC is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 4 open-market purchases ($1.26M) and 0 open-market sales () across all tracked filings.
Across 4 tracked purchases, Samsara BioCapital GP, LLC averaged -1030.9% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Samsara BioCapital GP, LLC profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.